BB vs SPRY · P/E 117, rev $549.1M vs rev $89.1M
BlackBerry Ltd (BB) versus ARS Pharmaceuticals, Inc (SPRY) — a side-by-side from cached financials, not a winner call.
BlackBerry Ltd (BB) is a software - infrastructure company listed on US.
ARS Pharmaceuticals, Inc (SPRY) is a biotechnology company listed on NASDAQ.
Latest reported BB revenue for 2026-02-28 was $549.1M. Net income was $53.2M. Revenue was up 2.7% from 2025-02-28 to 2026-02-28. BB currently screens at market cap $6.14B and trailing P/E 116.5.
Latest reported SPRY revenue for 2024-12-31 was $89.1M. Net income was $8.0M. Revenue was up 297063.3% from 2023-12-31 to 2024-12-31. SPRY currently screens at market cap $983.1M.
BB currently screens at market cap $6.14B and trailing P/E 116.5. SPRY currently screens at market cap $983.1M.
Not investment advice. Open the BB and SPRY stock pages for the full models.
Not investment advice.